Home » Newsletters » BioWorld Science

BioWorld Science

March 7, 2005

View Archived Issues

Parthenolide, a potent and selective anti-leukemia agent

New data on cardiovascular drugs presented at the ASCPT

An endogenous cannabinoid prevents prostate cancer cell invasion

Lansoprazole prevents type 14 rhinovirus infection

Long-acting insulin analog Albulin effective in diabetic mice

Lipid extract from palm fruit effective in testosterone-induced prostatic hypertrophy in rats

NBI-56418 shows promise in the treatment of endometriosis

Preliminary phase I data on the efficacy of TA-NIC in nicotine addiction

AZD-0865 prevents gastric acid secretion following single and repeated dosing

R-483 does not interact with drugs metabolized by cytochrome P450 isoenzymes

Ferring signs infertility agreement with Metris Therapeutics for vorozole

Phase IIb study for Biobypass

Millenia Hope to sponsor new malaria study

BioFocus in drug target agreement with Lilly

Crestor labeling revision approved by FDA

MM-039 studied in phase II trial for rheumatoid arthritis

Corixa and Lorantis to develop therapeutic hepatitis B vaccine

Sinovac's avian influenza vaccine in preclinical development

Chiron Fluvirin vaccine license reinstated by U.K.MHRA

Dynport Vaccine launches VIGIV to treat complications of smallpox vaccination

Thyrogen receives new European approval

Prous Institute Launches the Epistemic Drug Discovery Project

Novel combinations of anticancer agents reported by Angiogene researchers

Novel dopamine/noradrenaline/serotonin reuptake inhibitors imparted by NeuroSearch

Merck scientists present new dipeptidyl peptidase IV inhibitors for type 2 diabetes

New TGF-beta receptor type I kinase inhibitors claimed by Millennium Pharmaceuticals

Japan Tobacco scientists announce the synthesis of new HLGPa inhibitors for diabetes

Icatibant reported at the ASCPT meeting

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...